Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Porphyrin compounds and their use as MRI contrast agents

Porphyrin compounds and their use as MRI contrast agents

US Patent 10646595 · Granted May 12, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nitride-based semiconductor device and method for manufacturing the same2025
Semiconductor device and method for manufacturing the same2025
Method for treating crohn'S disease or ulcerative colitis by administering a com2016
Compounds and assays for controlling Wnt activity2015
Method for treating inflammation by administering a compound which binds LDL-rec2015
Detection or quantification of desirable target molecules, novel dyes, composite2014
Dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dy2014
Methods for mobile zinc measurement2013
Methods for detecting the presence, location or quantity of targets using novel 2013
Dyes linked to target molecules, oligonucleotides or polynucleotides comprising 2012
Sensors for fluorescence and magnetic resonance imaging2012
3-D molecular assembly and its applications for molecular display and moletronic2010